• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-A11/Kb转基因小鼠的培育:功能性CTL库及对人A11限制性CTL表位的识别

Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.

作者信息

Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari F V, Kubo R T, Grey H M, Sette A

机构信息

Cytel Corporation, San Diego, CA 92121, USA.

出版信息

J Immunol. 1997 Nov 15;159(10):4753-61.

PMID:9366399
Abstract

Transgenic mice expressing chimeric human (alpha1 and alpha2 HLA-A11 domains) and murine (alpha3, transmembrane, and cytoplasmic H-2Kb domains) class I molecules were derived. These mice were used as a model system to study the immunogenicity of human CTL epitopes and also to examine the aspects of Ag processing differences of mice vs man. Immunization of these mice with seven known HLA-A11-restricted CTL epitopes emulsified in IFA resulted in vigorous specific CTL responses. A larger panel of 45 A11-binding peptides was used to examine the relationship between immunogenicity in the HLA-A11/Kb transgenic mice and HLA-A11 binding capacity. Twenty-one of 28 (75%) peptides with high binding affinities (50% inhibitory concentration (IC50), 2-50 nM) and 7 of 13 (54%) intermediate binding peptides (IC50, 50-500 nM range) were immunogenic. In parallel, 19 of these peptides were used for in vitro primary immunizations of PBMC derived from HLA-A11 healthy human donors. It was found that 8 of 8 peptides that were able to elicit CTL in primary human in vitro cultures were also immunogenic in HLA-A11/Kb mice. Finally, HLA-A11/Kb transgenic mice were found to generate an A11/Kb restricted CTL response following immunization with influenza virus A/PR/8/34, suggesting that, at least to some extent, A11 epitopes are generated by transgenic mice as a result of natural in vivo processing and presentation.

摘要

构建了表达嵌合型人(α1和α2 HLA - A11结构域)和鼠(α3、跨膜和胞质H - 2Kb结构域)I类分子的转基因小鼠。这些小鼠被用作模型系统来研究人CTL表位的免疫原性,并考察小鼠与人在抗原加工差异方面的情况。用在不完全弗氏佐剂中乳化的7种已知HLA - A11限制性CTL表位免疫这些小鼠,可引发强烈的特异性CTL反应。使用一组更大的45种A11结合肽来考察HLA - A11/Kb转基因小鼠中的免疫原性与HLA - A11结合能力之间的关系。28种高结合亲和力肽(50%抑制浓度(IC50),2 - 50 nM)中有21种(75%)以及13种中等结合肽(IC50,50 - 500 nM范围)中有7种(54%)具有免疫原性。同时,其中19种肽用于对来自HLA - A11健康人类供体的外周血单个核细胞进行体外初次免疫。结果发现,在原代人体外培养中能够引发CTL的8种肽在HLA - A11/Kb小鼠中也具有免疫原性。最后,发现用甲型流感病毒A/PR/8/34免疫后,HLA - A11/Kb转基因小鼠产生了A11/Kb限制性CTL反应,这表明至少在一定程度上,A11表位是转基因小鼠在体内自然加工和呈递的结果。

相似文献

1
Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.HLA-A11/Kb转基因小鼠的培育:功能性CTL库及对人A11限制性CTL表位的识别
J Immunol. 1997 Nov 15;159(10):4753-61.
2
Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes.HLA-B*0702转基因小鼠的培育:功能性CTL库及对人B*0702限制性CTL表位的识别
Hum Immunol. 2003 Feb;64(2):211-23. doi: 10.1016/s0198-8859(02)00786-3.
3
Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.HLA-A2.1转基因小鼠中的细胞毒性T细胞反应。对HLA同种异体抗原的识别以及将HLA-A2.1用作限制元件。
J Immunol. 1989 Feb 15;142(4):1366-71.
4
Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.CD8与MHC I类分子α3结构域相互作用中的物种特异性。
J Immunol. 1992 Jul 1;149(1):136-42.
5
Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice.人Melan-A肽类似物在HLA-A*0201/Kb转基因小鼠中的免疫原性评估。
J Immunol. 1999 Mar 15;162(6):3566-73.
6
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.通过对HLA-A*0201结合肽的体内和体外免疫原性研究鉴定出的人乳头瘤病毒16型E6和E7编码的人CTL表位。
J Immunol. 1995 Jun 1;154(11):5934-43.
7
Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice.人类和人类白细胞抗原转基因小鼠中A2.1限制性细胞毒性T细胞库的异同
Eur J Immunol. 1996 Jan;26(1):97-101. doi: 10.1002/eji.1830260115.
8
Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.利用MHC I类转基因小鼠开发编码多个HLA限制性CTL表位的小基因DNA疫苗。
J Immunol. 1999 Apr 1;162(7):3915-25.
9
Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice.正常小鼠和HLA-Cw3转基因小鼠中细胞毒性T淋巴细胞对HLA-A2抗原的识别
Eur J Immunol. 1989 Apr;19(4):599-604. doi: 10.1002/eji.1830190404.
10
Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.同种特异性人和鼠的H-2限制性抗HLA T杀伤淋巴细胞对表达HLA分子的鼠细胞的特异性裂解作用。
Eur J Immunol. 1986 Jun;16(6):597-604. doi: 10.1002/eji.1830160603.

引用本文的文献

1
HLA-transgenic mouse models to study autoimmune central nervous system diseases.用于研究自身免疫性中枢神经系统疾病的 HLA 转基因小鼠模型。
Autoimmunity. 2024 Dec;57(1):2387414. doi: 10.1080/08916934.2024.2387414. Epub 2024 Aug 21.
2
Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy.鉴定新型 HLA-A*11:01 限制性 HPV16 E6/E7 表位和用于 HPV 相关癌症免疫治疗的 T 细胞受体。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2022-004790.
3
TCR Gene Therapy for Cancer.
T 细胞受体基因治疗癌症。
Methods Mol Biol. 2022;2521:95-128. doi: 10.1007/978-1-0716-2441-8_6.
4
T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles.在独特的本土 HLA 谱背景下的 T 细胞表位发现。
Front Immunol. 2022 May 6;13:812393. doi: 10.3389/fimmu.2022.812393. eCollection 2022.
5
HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people.HLA-A*11:01 限制性 CD8+ T 细胞对土著和非土著人群中甲型流感病毒和乙型流感病毒的免疫反应。
PLoS Pathog. 2022 Mar 7;18(3):e1010337. doi: 10.1371/journal.ppat.1010337. eCollection 2022 Mar.
6
Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells.用HIV-1 A亚型耐药整合酶对小鼠进行DNA免疫诱导的细胞免疫反应,对表达整合酶的腺癌细胞的生长和转移活性提供部分保护。
Microorganisms. 2021 Jun 4;9(6):1219. doi: 10.3390/microorganisms9061219.
7
ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery.ARTEMIS:一种新型的 HLA 限制性自身和疾病相关肽发现的质谱平台。
Front Immunol. 2021 Apr 23;12:658372. doi: 10.3389/fimmu.2021.658372. eCollection 2021.
8
Human class I major histocompatibility complex alleles determine central nervous system injury versus repair.人类I类主要组织相容性复合体等位基因决定中枢神经系统损伤与修复。
J Neuroinflammation. 2016 Nov 17;13(1):293. doi: 10.1186/s12974-016-0759-4.
9
Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation.用于研究 HLA I 类抗原呈递的改良转基因小鼠模型。
Sci Rep. 2016 Sep 16;6:33612. doi: 10.1038/srep33612.
10
Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes.HLA-A*11:01限制性结核分枝杆菌CD8(+) T细胞表位的鉴定
J Cell Mol Med. 2016 Sep;20(9):1718-28. doi: 10.1111/jcmm.12867. Epub 2016 Apr 12.